20n Bio Appoints Linghang Zhuang, Ph.D., as President, to lead the discovery of cyclic peptide drugs

Retrieved on: 2024-01-29 22:28:50

Tags for this article:

Click the tags to see associated articles and topics

20n Bio Appoints Linghang Zhuang, Ph.D., as President, to lead the discovery of cyclic peptide drugs. View article details on hiswai:

Excerpt

Published: Jan 29, 2024. MALVERN, Penn., Jan 31, 2023 /PRNewswire/ --20n Bio, a biotechnology company specializing in peptide drug discovery, ...

Article found on: www.biospace.com